SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Computers - Software >

Grey Cloak Tech (GRCK)

GRCK RSS Feed
Add GRCK Price Alert      Hide Sticky   Hide Intro
Moderator: i_like_bb_stock, RAND, Carjockey2, skichic, sjoseph, Pi_Sky2017
Search This Board: 
Last Post: 10/19/2017 2:26:08 AM - Followers: 129 - Board type: Free - Posts Today: 10


Social Media Links - Click Below
Image result for twitter iconImage result for facebook iconImage result for linkedin icon
 
 

Grey Cloak Tech Announces Q2 Results, Continues to Seek Acquisition Candidates

 

Las Vegas, Nevada (PRWEB) September 07, 2016

For the second quarter of 2016, revenues were $41,250 for the three months ended June 30, 2016, compared to $34,800 for the three months ended June 30, 2015, an increase of $6,450, or 19%. Revenues were $80,250 for the six months ended June 30, 2016, compared to $45,400 for the six months ended June 30, 2015, an increase of $34,850, or 77%. Net operating loss was $64,425 for the three months ended June 30, 2016, compared to $107,416 for the three months ended June 30, 2015, a decrease of $42,991. Net loss was $108,796 for the three months ended June 30, 2016, or $0.01 per share, compared to $107,388 for the three months ended June 30, 2015, or $0.01 per share, an increase of $1,408. The $0.01 loss per share is based on a total of 15,290,849 outstanding shares as of June 30 2016.

Grey Cloak's revenues were generated through sales of their debut product, Fraudlytic, which continues to serve key customers across a variety of sectors including telecom, retail, and the automotive industry. Fraudlytic was developed to combat the increasing threat of digital advertising fraud - also known as bot fraud or click fraud - which the Interactive Advertising Bureau (IAB) projects could cost unsuspecting advertisers $8.2 billion annually. More recently, research conducted by the World Federation of Advertisers (WFA) projected the cost could exceed $50 billion a year by 2025.

To stay ahead of the threat, Grey Cloak continues to improve upon their core product. Version 2.0 of the product was rolled out in early August. Updates to the Fraudlytic software included performance improvements and better data tracking.

"The company is excited about Fraudlytic's advancements, and we're looking forward to adding products to our portfolio that are able to leverage the Fraudlytic technology," says Fred Covely, CEO of Grey Cloak, "the company will continue to improve on its current click fraud detection software, develop other suites of software, and explore other software products through possible acquisitions."

Forward-Looking Statements

Safe Harbor Notice 
Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Grey Cloak Tech Inc. cautions that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. Grey Cloak Tech Inc. undertakes no obligation to revise these statements following the date of this news release.

For more information, visit http://www.greycloaktech.com.

Read the full story at http://www.prweb.com/releases/2016/09/prweb13660747.htm

 

 
Grey Cloak develops advanced software to overcome the most costly online security threats, including digital advertising fraud. Our mission is to revolutionize internet security by overcoming one threat at a time.
 
Image result for click fraud


 
Image result for click fraud Our debut cloud-based product, Fraudlytic, detects, tracks, and eliminates digital advertising fraud, a problem the Interactive Advertising Bureau (IAB) projects will cost unsuspecting advertisers $8.2 billion annually. As digital advertising is poised to overtake television advertising by 2019, according to PwC, the cost of online fraud threatens to grow exponentially. 


"Our mission is to revolutionize internet security by overcoming one threat at a time."

 


 

Fraudlytic™ is a cloud-based, secure platform that monitors internet traffic in real time, blocking malicious and false clicks, while allowing real consumers to view offers and buy.
 
The click-fraud phenomena is costing digital advertisers billions of dollars and to date there is only one way to stop it: effective detection and elimination software.
 
Grey Cloak Tech founders have deep roots in the digital marketing industry and observed this problem many years ago. Combining with internet security specialists and the best programmers in this field, Grey Cloak Tech set out to stop the malicious viruses (bots) that not only cause false clicks, but infect computers worldwide with other destructive elements.
 
Like a laser-guided weapon, Fraudlytic™ detects, analyzes, and destroys bots while allowing legitimate consumer traffic to click and view digital ads.

 

fraudlytic-bold_600x400 - Copy
Image result for click fraud

 
 


 

Impression Fraud: Click fraud is ever evolving via manipulations of impressions. Grey Shield applies state-of-the-art, ever evolving detection programming to swiftly analyze and prohibit:

 

Masked URLs
Cookie Hijacking
Device Hijacking
IP Spoofing
Domain ID Theft
Ad Stacking



Doorway Site Detection: Search engine “doorways” are artificial web pages that redirect visitors without their knowledge by cloaking their actual URLs. Grey Shield’s landing page auditor penetrates false doorways and permanently bars them from your potential customers.

 

Self Programmable SAAS solution: Reduce IT costs with Grey Shield’s easy-to-set-up campaigns that provide detailed reports based on users behavior or on the campaign level. It will tell you which marketing campaigns are effective and which are fraudulent so they can get a predictable ROI. You can either block the bad traffic so it never reaches your website or you can see it in the reporting and make your marketing decisions on future campaigns, phones, tablets, and laptops.
Grey Shield’s Arsenal of Algorithms Include:


 

Digital Fingerprinting
Advanced Geo Detection services
Pattern Recognition
Bot & Virus Infection Detection
Proxy Network IP Surveillance
Domain Masking Detection



Graceful Interface: Grey Cloak’s API integrates seamlessly into your analytics programs, Programmatic or RTB Networks, and Google, Yahoo, and AOL.

 

Geo Location Feature: Your ads run specific to the location of the device. For example, as a traveler changes states, his device will adjust your ad accordingly where he might see a different ad or be redirected to another website.

Non-approved States: Screen out non-approved states from specific ad campaigns from showing in states that are not approved for that product.

Target marketing: This functionality also allows you to geographically target your ad compaigns. You can determine a geographical radius corresponding to a store location or desirable zip code market.


 





AS is NOW 500M PER NVSOS AND THE OS IS PROBABLY AROUND 100M by now in guesstimation and growing each day with over

$750K in notes hitting but no one knows for sure as the TA is gagged! 


http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=Qp9lqrf8wRxAOc01e881UA%253d%253d&nt7=0





RS- REVERSE SPLIT PLANNED TO BE ANNOUNCED BEFORE DEC 2017

https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11887464 

 
Quote:
To approve an amendment to our Articles of Incorporation to 

effect a reverse stock split of our common stock at a ratio up to 1-for-

100, the exact ratio and timing of which will be set by our Board of

Directors at a future date no later than December 31,2017. 

The agenda item passed with votes as follows: 

For: 10,833,873 
Against: 370,762 
Abstain: 3,100 
Percentage Approving: 63.1% 

 
EQOVA LIFE SCIENCES Started their business per

NVSOS on AUGUST 1, 2017














LETTER OF INTENT SIGNED TO ACQUIRE EQOVA LIFE SCIENCES WITH AN ESTIMATED CLOSE OF 10/10/2017 PER GRCK CEO

https://eqova.com/

 

Eqova Life Sciences CEO 
 

Eqova Life Sciences’
Executive Team

Eqova’s management team brings 40 years of experience in the health product space. With sprawling expertise in functional medicine, product formulation, branding, direct sales, health practitioner partnerships and regulation & compliance.

Patrick Stiles

Co-Founder & CEO

Patrick is a serial entrepreneur who has spent most of the last decade working with Ph.D.s the world over to bring to market cutting edge health products that can transform people’s lives.

He is personally responsible for building numerous multi-million-dollar consumer health brands, helping thousands of people form dozens of countries with some of their most pressing health concerns.

He is a health startup veteran and expert in product formulation and health branding.

When Patrick isn’t working tirelessly to further his professional passions, you can find him salsa dancing with his wife, hiking in the Colorado Rockies, traveling internationally, volunteering with incarcerated youths or working on his own health with functional medicine.

Matthew Grabau

Co-Founder & CMO

Matt has grown a several nutraceutical ventures into multi-million-dollar operations from start-up. In his tenure with Eqova, he has been instrumental in operational development from concept to current day, serving a central role in the creation of the company’s proprietary business model, procuring raw material and personnel for start-up, establishing relationships with distributors and sales personnel, securing patented delivery systems and overseeing sales operations.

Previously, Matt was the CEO of Rocky Mountain Pro Nutrients. It was here that he and his team of sales representatives were responsible for growing one of the nation’s premier professional nutraceutical business from inception to $5 million in less than four years. His organization generated an average year-over-year growth of 270%, building towards a monthly volume of over 24,000 units.

Matt holds a Bachelor of Science degree from University of Northern Colorado and enjoys time with his wife and 3 children.

Dr. Paul Dragul

Chief Medical Officer

Dr. Dragul has spent over 4 decades studying and practicing medicine. He’s focused on bringing innovative new techniques and health practices to his patients. His greatest pride is helping people live healthier, happier lives.

He received his Ph.D. with Honors in Pharmacology & M.D. from the University of Cincinnati. He practiced at the United States Public Health Service & as the General Medical Officer for the Indian Hospital in Gallup New Mexico before practicing privately in Colorado.

Jesse Cothran

Compliance

With over 17 years of experience in the industry, Jesse Cothran is a dietary supplement expert. He has helped numerous companies expand business operations into more than 55 countries internationally and navigate through various federal, state, and foreign regulatory and quality requirements. Having started his career in a call center and eventually working his way up to become an executive, he is known for understanding the industry inside and out and helping companies build multi-million dollar businesses where quality and compliance are an integral part of the corporate culture.

 

Why Eqova Life Sciences?

Our Mission is to change the health of people the world over with safe, effective and standardized full spectrum hemp oil health products through their trusted professional medical health practitioners.

Cannabinoid Rich Health Supplements are powerful tools. Many people in the general public know this. And demand this benefits for their own health.



 
 

Eqova’s Mission & Core Values

Eqova Life Sciences, Inc. is the world’s very first full spectrum hemp oil brand exclusively created for medical practitioners.

 

Our Mission

is to change the health of people the world over with safe, effective and standardized full spectrum hemp oil health products through their trusted professional medical health practitioners.

Cannabinoid Rich Health Supplements are powerful tools. Many people in the general public know this, and demand these benefits for their own health.

But nothing is more effective than a holistic approach to modern medicine. Incorporating the very best of the western healthcare model with natural solutions when and where appropriate.

 

Eqova Believes

the most effective and safe application of full spectrum hemp oil health products is under the care and guidance of a medical practitioner.

This may allow regular people to achieve extraordinary health.

Because core regular people can achieve vibrant health without always resulting to prescription drugs or surgeries.

No one knows their patients’ health like the medical professionals who work with them to improve it.



NO MODS ARE TO DELETE, ALTER or DO ANYTHING ABOVE THIS.  IF YOU WANT TO ADD CONTENT PLEASE DO SO BELOW PER THE IHUB TOS.  

SureTrader
Interactive Brokers Advertisement
GRCK
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GRCK News: Current Report Filing (8-k) 10/04/2017 05:18:56 PM
GRCK News: Statement of Ownership (sc 13g) 09/29/2017 04:01:46 PM
GRCK News: Quarterly Report (10-q) 08/18/2017 05:15:26 PM
GRCK News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 08/14/2017 05:12:52 PM
GRCK News: Statement of Changes in Beneficial Ownership (4) 05/25/2017 01:18:45 PM
PostSubject
#5764  Sticky Note QB Tier action, hell yes >>click>> RAND 10/19/17 02:26:07 AM
#3673  Sticky Note OCTOBER 6TH GREY/EQOVA MERGER UPDATE: Grey Cloak Tech Inc. Adam16 10/06/17 04:25:23 PM
#2796  Sticky Note COMPANY GOING OTCQB? CERTIFICATION FILED TODAY http://www.otcmarkets.com/financi Adam16 10/04/17 06:44:30 PM
#1051  Sticky Note Wow 13G just out Oakmore Opportunity Fund bought i_like_bb_stock 09/29/17 04:06:51 PM
#5764   QB Tier action, hell yes >>click>> RAND 10/19/17 02:26:07 AM
#5763   OTCQB means free L2 quotes http://www.otcmarkets.com/stock/GRCK/quote KeepItRealistic 10/19/17 01:38:48 AM
#5762   OTCQB catalyst —> Checked !!! http://www.otcmarkets.com/stock/GRCK/quote Acq KeepItRealistic 10/19/17 01:35:10 AM
#5761   Sell the news smyork 10/19/17 01:19:12 AM
#5760   UPLIST TO OTCQB COMPLETE! https://www.otcmarkets.com/stock/GRCK/quote jujufumpkins 10/19/17 01:05:36 AM
#5759   The cross is coming tomorrow. Looks really Chess Master 10/19/17 01:01:13 AM
#5758   Uplisting should be tomorrow. If so then Chess Master 10/19/17 12:59:16 AM
#5757   Yep it looks great. I'm in the stock Doc Holliday 10/19/17 12:38:48 AM
#5756   Did you see that chart? Looks like a BluSkies 10/19/17 12:15:10 AM
#5755   Just saw the close. Good close. Getting ready Doc Holliday 10/19/17 12:13:03 AM
#5754   OTCQB uplist not tomorrow the 18th https://www.otcmarkets.com/market-activity/ot KeepItRealistic 10/18/17 11:09:01 PM
#5753   Flipping this has been more challenging this week KeepItRealistic 10/18/17 10:48:54 PM
#5752   $GRCK hypothetical Potential KeepItRealistic 10/18/17 09:46:53 PM
#5751   Should hear some news tomorrow. Pennywiserr 10/18/17 09:32:12 PM
#5750   That says it all to me! It’s a Backstabbed 10/18/17 08:45:43 PM
#5749   Today’s 4 tweets from Company Are All based KeepItRealistic 10/18/17 08:30:08 PM
#5748   thanks jb29 10/18/17 06:55:09 PM
#5747   I agree, El Chico. The Apostle 10/18/17 05:28:50 PM
#5746   graph looks too good to be true....suspiciously the chico hombre2 10/18/17 05:01:11 PM
#5745   From last PR (anyday now) On September 19, 2017, KeepItRealistic 10/18/17 04:55:46 PM
#5744   Uplisting to OTCQB Closure of Acquisition (see last PR) KeepItRealistic 10/18/17 04:54:17 PM
#5743   Only a tiny cross trade of 62k No t KeepItRealistic 10/18/17 04:46:01 PM
#5742   hello THE APOSTLE....please fill me in on what jb29 10/18/17 04:44:39 PM
#5740   looking good. we will bust a move in Backstabbed 10/18/17 02:53:37 PM
#5738   Bids are moving upward! Ask moving upward! Pennywiserr 10/18/17 02:19:34 PM
#5737   You mean like the one that can get KeepItRealistic 10/18/17 02:06:18 PM
#5736   We know great NEWS is coming.... Drugdoctor 10/18/17 01:58:34 PM
#5734   That's when you buy. Quietly moving up. The Apostle 10/18/17 01:51:40 PM
#5733   No volume. Nobody cares. Other plays running big time smyork 10/18/17 01:50:33 PM
#5732   Easy Peeps waiting for this to dip will miss KeepItRealistic 10/18/17 01:49:15 PM
#5731   The reversal has begun. The Apostle 10/18/17 01:48:57 PM
#5730   Thanks smyork. It's looking great. Thanks for your LB77 10/18/17 01:48:29 PM
#5729   We should be .10 very very soon! Drugdoctor 10/18/17 01:48:02 PM
#5728   Those .014's will look very cheap next week :-) Drugdoctor 10/18/17 01:47:21 PM
#5727   Ask getting stacked. Bid dropping off. Same go smyork 10/18/17 01:36:15 PM
#5726   All aboard!!! Train leaving!!! The Apostle 10/18/17 01:32:03 PM
#5725   Unlimited .014s to go around here smyork 10/18/17 01:25:37 PM
#5724   Gearing up to pop higher eod...looking for a chris20 10/18/17 01:25:11 PM
#5723   Indeed. Hoping for Bill or someone to provide number___9 10/18/17 01:20:57 PM
#5722   Good seeing you here. We have a gem. The Apostle 10/18/17 01:20:51 PM
#5721   Level 2 so thin to .02. Pennywiserr 10/18/17 01:14:48 PM
#5720   Thanks Backstabbed buddy! doogdilinger 10/18/17 12:58:54 PM
#5719   Will be "go time" whenever the company announces smyork 10/18/17 12:52:28 PM
#5718   Need volume here. lostcoast1 10/18/17 12:50:39 PM
#5717   Should be *GO TIME* today or tomorrow. Pennywiserr 10/18/17 12:43:38 PM
#5716   35 million market cap puts us at 37?cents KeepItRealistic 10/18/17 12:41:39 PM
#5715   Not at all. Key is patience, not chasing..... XMAN 10/18/17 12:37:14 PM
#5714   Take off Batman412 10/18/17 12:37:03 PM
#5713   Going to start moving into close today, updates boomer 10/18/17 12:32:30 PM
#5712   Welcome Doug ;-) Backstabbed 10/18/17 12:27:56 PM
PostSubject